Skip to content

Neramexane

DRUG9 trials

Sponsors

Forest Laboratories, Merz Pharmaceuticals GmbH

Conditions

Alzheimer's DiseaseHealthyHealthy SubjectsMetabolism of NeramexaneTinnitus

Phase 1

Study to Evaluate the Effects of Neramexane on the Pharmacokinetics of a Combined Drospirenone/Ethinyl Estradiol Oral Contraceptive in Healthy Female Subjects
CompletedNCT00915174
Merz Pharmaceuticals GmbHHealthy
Start: 2009-06-30End: 2009-11-30Updated: 2011-05-06
Open, Single Center, Three Periods, Fixed Sequence Design Study on the Effects of Clopidogrel Co-administration on the Pharmacokinetics of Neramexane
CompletedNCT00936026
Merz Pharmaceuticals GmbHHealthy Subjects
Start: 2009-07-31End: 2009-12-31Updated: 2011-02-08
Study Analyzing the Effect of Rifampicin Administration on the Pharmacokinetics of Neramexane Mesylate
CompletedNCT00955760
Merz Pharmaceuticals GmbHHealthy
Start: 2009-08-31End: 2009-12-31Updated: 2011-02-08
Changes in the Renal Excretion of Neramexane by Acidification of Urinary pH Study With and Without Application of a Urinary pH Acidification Regimen
CompletedNCT00972127
Merz Pharmaceuticals GmbHHealthy
Start: 2009-10-31End: 2009-12-31Updated: 2011-02-07
Evaluation of Dose-Dependent Repeated-Dose Neramexane Effects on Cardiac Repolarisation (QT/QTc Interval Duration): Electrocardiogram (ECG) Study in Healthy Adult Subjects
CompletedNCT00978614
Merz Pharmaceuticals GmbHHealthy Subjects
Start: 2009-09-30End: 2010-04-30Target: 126Updated: 2011-02-15
Evaluation of Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of Neramexane Mesylate in Healthy Japanese Subjects
CompletedNCT00983099
Merz Pharmaceuticals GmbHHealthy
Start: 2009-09-30End: 2010-09-30Updated: 2011-04-15
A Single Center, Open-Label Study to Quantify Metabolites of [14C]-Neramexane in Plasma and Urine in Healthy Male Subjects
CompletedNCT01109680
Merz Pharmaceuticals GmbHMetabolism of Neramexane
Start: 2010-04-30End: 2010-06-30Target: 8Updated: 2011-02-08

Phase 2

Phase 3

Related Papers